Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers July 22, 2014
Pharmacy Choice - Pharmacy News - July 22, 2014

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
7/22/14 - Access Pharmaceuticals Receives 510(K) FDA Marketing Clearance For ProctiGardâ?¢
DALLAS and NEW YORK, July 22, 2014/ PRNewswire/-- ACCESS PHARMACEUTICALS, INC., a developer of new products for oncology supportive care, announced today that it has received 510 marketing clearance from the U.S. Food and Drug Administration for ProctiGardâ?¢, its novel treatment for symptomatic management of rectal mucositis. The Company indicated
7/22/14 - Cytonics Announces FDA Approval of an Investigational New Drug Application for the APIC Cell-Free System
Cytonics Corporation has announced that an Investigational New Drug application for a phase I/II clinical trial of the company's APIC Cell-Free System has been approved by the FDA. The system is indicated for the rapid preparation of concentrated protease inhibitors in plasma, specifically Alpha-2-Macroglobulin, for the treatment of mild to moderat
7/22/14 - Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders
--Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, announced today that the U.S. Food and Drug Administration, or the FDA, cleared Galmed's Investigational New Drug, or IND, applicatio
7/22/14 - Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
--Halozyme Therapeutics, Inc. today announced that it has resumed enrollment and dosing of patients in its ongoing Phase 2 trial evaluating PEGPH20 in patients with pancreatic cancer under the revised clinical protocol agreed to with the FDA in June. PEGPH20 is an investigational PEGylated form of Halozyme's proprietary recombinant human hyaluronid
7/22/14 - Spectral Diagnostics announces shareholder approval of its up to $18.2 million offering
/CNW/- Spectral Diagnostics Inc. today announced that at the special meeting of shareholders of the Corporation held earlier today, Shareholders overwhelmingly approved the terms of the previously announced proposed non-brokered private placement of the Corporation of up to $18.2 million. FDA approval for its lead theranostics product for the treat
7/22/14 - Teleflex Receives FDA Clearance For ARROW-ClarkTM VectorFlow Chronic Hemodialysis Catheter
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510 clearance to market its ARROW-Clarkâ?¢ VectorFlowâ?¢ Chronic Hemodialysis Catheter. Timothy Clark, M.D., the VectorFlowTM Catheter features a symmetrical tip design that allows ease of placement and sustained high

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Lupus: What You Need to Know
This lesson is supported by:
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement